Journal Article10.1016/J.JCLINEPI.2010.04.026
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon H. Guyatt,Andrew D Oxman,Elie A. Akl,Regina Kunz,Gunn Elisabeth Vist,Jan Brozek,Susan L Norris,Yngve Falck-Ytter,Paul Glasziou,Hans deBeer,Roman Jaeschke,David Rind,Joerg J Meerpohl,Philipp Dahm,Holger J. Schünemann +14 more
TL;DR: The GRADE process begins with asking an explicit question, including specification of all important outcomes, and provides explicit criteria for rating the quality of evidence that include study design, risk of bias, imprecision, inconsistency, indirectness, and magnitude of effect.
read more
About: This article is published in Journal of Clinical Epidemiology. The article was published on 01 Apr 2011. The article focuses on the topics: Evidence-based medicine & Evidence-based practice.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes
Gordon H. Guyatt,Kristian Thorlund,Andrew D Oxman,Stephen D. Walter,Donald L. Patrick,Toshi A. Furukawa,Bradley C. Johnston,Paul J. Karanicolas,Elie A. Akl,Gunn Elisabeth Vist,Regina Kunz,Jan Brozek,Lawrence L. Kupper,Sandra L. Martin,Joerg J Meerpohl,Pablo Alonso-Coello,Robin Christensen,Holger J. Schünemann +17 more
TL;DR: Alternatives include presenting results in the units of the most popular or interpretable measure, converting to dichotomous measures and presenting relative and absolute effects, presenting the ratio of the means of intervention and control groups, and presenting the results in minimally important difference units.
619
The management of antithrombotic agents for patients undergoing GI endoscopy
Ruben D. Acosta,Neena S. Abraham,Vinay Chandrasekhara,Krishnavel V. Chathadi,Dayna S. Early,Mohamad A. Eloubeidi,John A. Evans,Ashley L. Faulx,Deborah A. Fisher,Lisa Fonkalsrud,Joo Ha Hwang,Mouen A. Khashab,Jenifer R. Lightdale,V. Raman Muthusamy,Shabana F. Pasha,John R. Saltzman,Aasma Shaukat,Amandeep K. Shergill,Amy Wang,Brooks D. Cash,John M. DeWitt +20 more
TL;DR: Ruben D. Acosta as discussed by the authors, Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member), Vinay Chandrasekhara, MD; Krishnavel V. Chathadi; Mouen A. Khashab; Shabana F. Pasha; and John R. DeWitt.
614
Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated October 2017.
Jean-Marc Dumonceau,Andrea Tringali,Ioannis S. Papanikolaou,Daniel Blero,Benedetto Mangiavillano,Arthur Schmidt,Geoffroy Vanbiervliet,Guido Costamagna,Jacques Devière,Jesús García-Cano,Tibor Gyökeres,Cesare Hassan,Frédéric Prat,Peter D. Siersema,Jeanin E. van Hooft +14 more
TL;DR: Preoperative biliary drainage should be reserved for patients with cholangitis, severe symptomatic jaundice, or delayed surgery, or for before neoadjuvant chemotherapy in jaundiced patients.
Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy
Mukesh M. Agarwal,Michel Boulvain,Edward J. Coetzee,Stephen Colagiuri,Maicon Falavigna,Moshe Hod,Sara Meltzer,Boyd E. Metzger,Yasue Omori,Ingvars Rasa,Maria Inês Schmidt,Veerasamy Seshiah,David Simmons,Eugene Sobngwi,Maria Regina Torloni,Huixia Yang +15 more
- 01 Jan 2013
TL;DR: Each health service will need to assess their burden of hyperglycaemia in pregnancy and decide if and how it will implement programmes to test for and treat such women.
599
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.
Charles L. Daley,Jonathan M. Iaccarino,Christoph Lange,Emmanuelle Cambau,Richard J. Wallace,Claire Andrejak,Erik C. Böttger,Jan Brozek,David E. Griffith,Lorenzo Guglielmetti,Lorenzo Guglielmetti,Gwen A. Huitt,Shandra L Knight,Philip Leitman,Theodore K. Marras,Kenneth N. Olivier,Miguel Santin,Jason E. Stout,Enrico Tortoli,Jakko van Ingen,Dirk Wagner,Kevin L. Winthrop +21 more
TL;DR: This guideline focuses on pulmonary disease in adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as Mycobacterium avium complex, MycOBacterium kansasii, and Myc Cobacterium xenopi among the slowly growing NTM and MyCobacterius abscessus among the rapidly growing N TM.
References
•Journal Article
Cochrane Handbook for Systematic Reviews of Interventions
Abstract: The Cochrane Handbook for Systematic Reviews of Interventions is the official document that describes in detail the process of preparing and maintaining Cochrane systematic reviews on the effects of healthcare interventions.
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt,Andrew D Oxman,Gunn Elisabeth Vist,Regina Kunz,Yngve Falck-Ytter,Pablo Alonso-Coello,Holger J. Schünemann +6 more
TL;DR: The advantages of the GRADE system are explored, which is increasingly being adopted by organisations worldwide and which is often praised for its high level of consistency.
What is “quality of evidence” and why is it important to clinicians?
Gordon H. Guyatt,Andrew D Oxman,Regina Kunz,Gunn Elisabeth Vist,Yngve Falck-Ytter,Holger J. Schünemann +5 more
TL;DR: Guideline developers use a bewildering variety of systems to rate the quality of the evidence underlying their recommendations as mentioned in this paper, some are facile, some confused, and others sophisticated but complex.
•Book
Clinical practice guidelines : directions for a new program
Marilyn J. Field,Kathleen N. Lohr +1 more
- 01 Jan 1990
TL;DR: This clinical practice guidelines directions for a new program, it will really give you the good idea to be successful.
1.8K
Going from evidence to recommendations
Gordon H. Guyatt,Andrew D Oxman,Regina Kunz,Yngve Falck-Ytter,Gunn Elisabeth Vist,Alessandro Liberati,Holger J. Schünemann +6 more
TL;DR: The GRADE system classifies recommendations made in guidelines as either strong or weak, and the meaning of these descriptions and their implications for patients, clinicians, and policy makers are explored.